Extending Pipeline of New Drugs and Vaccines Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment […]
Monoclonal Antibody Therapeutics (mABs) Market was valued at US$ 192.04 Billion in 2022 and is expected to reach to US$ 542.80 Billion by 2030; it is estimated to record a CAGR of 13.9% from 2022 to 2030
Production of mAB-Based Drugs to Treat Several Diseases Drives Market Growth Monoclonal antibody therapeutics (mABs) are employed to treat a wide range of diseases, including cancer, autoimmune diseases, and metabolic diseases. Such drugs produced by biopharmaceutical companies and scientific research institutes have gained significant attention in the global market due to their high specificity, strong […]
Myopia Treatment Market was valued at US$ 10,276.67 Million in 2022 and is expected to reach to US$ 19,571.85 Million by 2030; it is estimated to record a CAGR of 8.39% from 2022 to 2030
North America accounted for the largest share of the global myopia treatment market in 2022. The market in Asia Pacific is expected to grow at the highest CAGR from 2022 to 2030. The US myopia treatment market is expected to experience significant growth in the coming years. The prevalence of myopia has been increasing in […]
Microbiome Therapeutics Market was valued at US$ 375.92 Million in 2022 and is expected to reach to US$ 813.38 Million by 2030; it is estimated to record a CAGR of 10.1% from 2022 to 2030
The potential of gut microbiota in maintaining human health and inflow of funds to ameliorate microbiome discovery pipeline bolster the microbiome therapeutics market size. However, the high cost of development and production hinders the microbiome therapeutics market growth. Increasing R&D to Gain Better Understanding of Human Microbiome is creating Opportunity for Microbiome Therapeutics Market Growth […]
Empty Capsules Market was valued at US$ 6.75 Billion in 2022 and is expected to reach to US$ 12.52 Billion by 2030; it is estimated to record a CAGR of 8.0% from 2022 to 2030
Empty capsules are made of gelatin, hydroxypropyl methylcellulose (HPMC), pullulan, and starch. These capsules can be used to fill formulations that are used to treat acute and chronic diseases, cancer, and common diseases such as colds and cough. They are also used to package nutritional supplement formulations, antacid and anti-flatulence medications, and personalized medicines. North […]
Drug Discovery Services Market was valued at US$ 19,539.00 million in 2022 and is expected to reach to US$ 56,783.29 million by 2030; it is estimated to record a CAGR of 14.3% from 2022 to 2030
Increasing demand for novel therapies across a wide range of therapeutic areas, and rising R&D expenditure in the pharmaceutical and biotechnology industries are driving the drug discovery services market. However, the high cost of drug discoveries hinders the drug discovery services market growth. Increasing Prevalence of Chronic Diseases is Driving The Drug Discovery Services Market […]
Malaria And Sickle Cell Disease Treatment Market was valued at US$ 4,457.15 million in 2022 and is expected to reach US$ 29,179.60 million by 2030; it is estimated to record a CAGR of 26.5% from 2022 to 2030
Asia Pacific is the fastest-growing region in the global malaria and sickle cell disease treatment market. North America accounted for the largest share of the global malaria and sickle cell disease treatment market in 2022. In the region, the US held the largest malaria and sickle cell disease treatment market share and is anticipated to […]
Cervical Cancer Treatment Market was valued at US$ 9,433.94 million in 2022 and is expected to reach US$ 14,074.08 million by 2030; it is estimated to record a CAGR of 5.13% from 2022 to 2030
Cancer is becoming one of the main causes of mortality across the globe. According to the World Health Organization (WHO), cancer was the top cause of death for individuals under the age of 70 in 183 nations, while in 123 other countries, it was the fourth most common cause of death globally in 2019. Furthermore, […]
Alzheimer’s Drugs Market was valued at US$ 6.21 billion in 2022 and is expected to reach US$ 22.01 billion by 2030; it is estimated to record a CAGR of 17.1% from 2022 to 2030
Asia Pacific is the fastest-growing market for Alzheimer’s drugs. In 2022, North America held the largest share of the global Alzheimer’s drugs market owing to extensive research and development activities by pharmaceutical companies, and prevalence of AD and associated dementia in the aging population in the region. According to the Alzheimer’s Association, in 2023, over […]
ADHD Therapeutics Market was valued at US$ 28,594.55 billion in 2022 and is expected to reach US$ 64,742.37 billion by 2030; it is estimated to record a CAGR of 10.8% from 2022 to 2030
North America held the largest share of the global ADHD therapeutics market in 2022. In the region, the US held the largest ADHD therapeutics market share in 2022 and is estimated to continue its dominance from 2022 to 2030. The US has a high prevalence of ADHD, which propels the ADHD therapeutics market growth. According […]